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Sir,
The most common site of metastatic disease in melanoma is
regional lymph nodes. Several well-documented factors predictive
of regional nodal metastasis particularly include tumour ulceration
and thickness (Balch et al, 2003). I read with great interest the
article of Shields et al (2004), who have proven that lymphatic
capillary density can be used to discriminate between melanomas
that will subsequently metastasise and ones that will not. Their
prognostic index based on immunohistochemically measured
lymphatic capillary density in combination with lymphatic
invasion and tumour thickness enables clear discrimination
between metastatic and nonmetastatic human malignant melano-
ma. Lymphatic capillaries are the functional units of the lymphatic
system and form the drainage pathways for interstitially injected
radiocolloid in lymphoscintigraphy. Lymphoscintigraphy enables
us to identify and localise the sentinel lymph nodes of primary
tumours exhibiting lymphogenic metastatic potential. The findings
of Shields et al (2004) now provide immunohistochemical evidence
that helps explain the results of our recent prospective lymphos-
cintigraphic feasibility study on 276 melanoma patients (Maza et al,
2003). We found a relationship between the speed at which sentinel
lymph nodes appear on dynamic lymphoscintigraphic scans and
their metastatic involvement. The faster the lymphatic drainage
takes place, the greater the metastatic involvement of the sentinel
lymph nodes seems to be. The higher the lymphatic capillary
density, the more the radiocolloid can presumably be absorbed. In
other words, lymphatic capillary density may provide a histo-
pathological explanation for the mechanisms involved in lym-
phoscintigraphic drainage speed. Hence, consistent evidence has
been presented that lymphogenic pathway studies can yield
predictors of metastatic spread. A fast scintigraphic appearance
time, assessed under standardised conditions (Maza et al, 2003),
seems to provide a new parameter for predicting the primary
pathway and the likelihood of lymphogenic metastatic spread to
allow surgeons and pathologists to better focus on determined
lymph nodes. Now, it remains to be elucidated if sentinel lymph
nodes can be excised in chronological order of their scintigraphic
appearance, thereby possibly avoiding excision of slowly draining
nodes. This approach would minimise morbidity and enhance
diagnostic accuracy, particularly in multidirectional lymphatic
drainage systems with sentinel lymph nodes in different basins.
REFERENCES
Balch CM, Buzaid AC, Soong S-J, Atkins MB, Cascinelli N,
Coit DG, Fleming ID, Gershenwald JE, Houghton Jr A,
Kirkwood JM, McMasters KM, Mihm MF, Morton DL,
Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2003)
New TNM melanoma staging system: linking biology and
natural history to clinical outcomes. Semin Surg Oncol 21:
43–52
Maza S, Valencia R, Geworski L, Sandrock D, Zander A, Audring H, Dra ¨ger
E, Winter H, Sterry W, Munz DL (2003) Influence of fast lymphatic
drainage on metastatic spread in cutaneous malignant melanoma: a
prospective feasibility study. Eur J Nucl Med Mol Imaging 30: 538–544
Shields JD, Borsetti M, Rigby H, Harper SJ, Mortimer PS, Levick JR,
Orlando A, Bates DO (2004) Lymphatic density and metastatic spread in
human malignant melanoma. Br J Cancer 90: 693–700
*Correspondence: Dr DL Munz; E-mail: dieter.munz@charite.de
Published online 8 June 2004
British Journal of Cancer (2004) 91, 193
& 2004 Cancer Research UK All rights reserved 0007– 0920/04 $30.00
www.bjcancer.com